Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Jardiance
Jardiance
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes
Mon, 06/12/17 - 10:15 pm
JNJ
heart attacks
Invokana
diabetes
amputation. Eli Lilly
Boehringer Ingelheim
Jardiance
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin
2 Reasons Eli Lilly is Getting Crushed
Barron's
Wed, 04/26/17 - 12:00 am
Eli Lilly
earnings
Jardiance
diabetes
baricitinib
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
ADA guidelines highlight new Jardiance label
BioPharma Dive
Mon, 12/19/16 - 11:39 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
Victoza
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
Medical Marketing and Media
Tue, 12/6/16 - 10:05 pm
Boehringer Ingelheim
Eli Lilly
cardiologists
diabetes
Jardiance
Lilly Shares Spike On Jardiance Approval (LLY)
Investopedia
Sat, 12/3/16 - 12:04 am
Eli Lilly
FDA
Jardiance
type 2 diabetes
cardiovascular death
Fate of Lilly's Jardiance franchise rests on FDA's delayed heart-benefits indication
Fierce Pharma
Tue, 11/1/16 - 10:13 am
Eli Lilly
Jardiance
FDA
diabetes
Boehringer Ingelheim
Eli Lilly Has Catalysts Ahead
TheStreet.com
Mon, 07/25/16 - 10:51 am
Eli Lilly
earnings
solamezumab
Jardiance
U.S. panel backs claim Lilly diabetes drug cuts cardiac death
Yahoo/Reuters
Tue, 06/28/16 - 10:55 pm
FDA
advisory panels
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
Is Merck & Co., Inc Januvia In Trouble? FDA Panel Decides Tomorrow
Bidness, ETC
Mon, 06/27/16 - 03:13 pm
Merck
Januvia
diabetes
FDA
advisory panels
Jardiance
Eli Lilly
FDA panel to vote whether diabetes drug cuts cardiac death
Yahoo/Reuters
Fri, 06/24/16 - 04:06 pm
FDA
advisory panels
diabetes
Eli Lilly
Boehringer Ingelheim
Jardiance
Eli Lilly Shows Terrific Innovation
Seeking Alpha
Thu, 06/23/16 - 09:18 am
Eli Lilly
Jardiance
olaratumab
abemaciclib
innovation
diabetes
cancer
Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit
BioPharma Dive
Wed, 06/15/16 - 05:42 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
kidney disease
New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
Yahoo
Sun, 06/12/16 - 09:56 pm
type 2 diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Eli Lilly’s Jardiance Can be a Threat to Novartis’ Entresto
Bidness, ETC
Wed, 04/20/16 - 09:46 pm
Eli Lilly
Jardiance
Novartis
Entresto
Boehringer Ingelheim
diabetes
heart failure
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Eli Lilly And Boehringer Reveals Study On Jardiance For Treatment Heart Failure
Yahoo/Benzinga
Tue, 04/19/16 - 09:47 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
chronic heart failure
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Jardiance
SGLT2 inhibitor
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »